PhaseBio Pharmaceuticals Inc 4 SEC Filings

Filed On	Filing
19 May 2023	Form 4: van den Broek Richard, Director Received 3,750 shares as a grant or award · Exercised 3,750 Restricted Stock Units
19 May 2023	Form 4: Thorp Clay, Director Received 3,750 shares by exercise or conversion · Acquired 3,750 Restricted Stock Units (Option Exercise/Conversion)
19 May 2023	Form 4: Humphries William D., Director Received 2,538 shares by exercise or conversion
19 May 2023	Form 4: Harrigan Edmund, Director Received 3,750 shares by exercise or conversion · Acquired 3,750 Restricted Stock Units (Option Exercise/Conversion)
19 May 2023	Form 4: Sapir Alex, Director Received 3,750 shares by exercise or conversion
19 May 2023	Form 4: Loewy Caroline M, Director Received 3,750 shares by exercise or conversion
19 May 2023	Form 4: Hutson Nancy J, Director Received 3,750 shares by exercise or conversion
26 Oct 2022	Form 4: New Enterprise Associates 13 Lp, 10% owner and 5 others Sold 1,784,109 shares ($262K)
24 May 2022	Form 4: Arnold Susan Elizabeth, SVP, Technical Operations Received 10,917 shares as a grant or award ($7.44K)
24 May 2022	Form 4: Mow Jonathan P, Director Received 10,918 shares as a grant or award ($7.44K)
24 May 2022	Form 4: Burkhardt Glen, SVP of Human Resources Received 11,248 shares as a grant or award ($7.66K) · Sold 11,248 shares ($8.89K)
24 May 2022	Form 4: Hanson Kristopher, SVP and General Counsel Received 4,831 shares as a grant or award ($3.29K)
24 May 2022	Form 4: Birchall Jonathan, Chief Commercial Officer Received 20,000 shares as a grant or award ($13.6K)
24 May 2022	Form 4: Sharp John P, Chief Financial Officer Received 6,026 shares as a grant or award ($4.11K)
20 May 2022	Form 4: Humphries William D., Director Granted 17,500 Non-employee Director Stock Option (right to buy) · Granted 3,750 Restricted Stock Units
20 May 2022	Form 4: Thorp Clay, Director Granted 17,500 Non-employee Director Stock Option (right to buy) · Granted 3,750 Restricted Stock Units
20 May 2022	Form 4: Hutson Nancy J, Director Granted 17,500 Non-employee Director Stock Option (right to buy) · Granted 3,750 Restricted Stock Units
20 May 2022	Form 4: Sapir Alex, Director Granted 17,500 Non-employee Director Stock Option (right to buy) · Granted 3,750 Restricted Stock Units
20 May 2022	Form 4: Loewy Caroline M, Director Granted 17,500 Non-employee Director Stock Option (right to buy) · Granted 3,750 Restricted Stock Units
20 May 2022	Form 4: Harrigan Edmund, Director Granted 17,500 Non-employee Director Stock Option (right to buy) · Granted 3,750 Restricted Stock Units

Comments